|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current Assets | |||||||||||
| Cash | |||||||||||
| Restricted cash | |||||||||||
| Cash and cash equivalents | |||||||||||
| Accounts receivable, net | |||||||||||
| Inventory | |||||||||||
| Prepaid expense | |||||||||||
| Other receivables and other current assets | |||||||||||
| Tax recoverable | |||||||||||
| Due from related party | |||||||||||
| Total Current Assets | |||||||||||
| NON-CURRENT ASSETS | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Construction in progress | |||||||||||
| Intangible assets, net | |||||||||||
| Operating lease right-of-use assets, net | |||||||||||
| Security deposits | |||||||||||
| Deferred financing costs | |||||||||||
| Total non-current assets | |||||||||||
| TOTAL ASSETS | |||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
| Current Liabilities | |||||||||||
| Accounts and other payables and accruals | |||||||||||
| Unearned revenue | |||||||||||
| Operating lease liabilities, current | |||||||||||
| Loan payable, current | |||||||||||
| Tax payable | |||||||||||
| Due to related party | |||||||||||
| Obligation under secured borrowing arrangement | |||||||||||
| Total Current Liabilities | |||||||||||
| Operating lease liabilities, non-current | |||||||||||
| Total non-current liabilities | |||||||||||
| Loan payable, non-current | |||||||||||
| TOTAL LIABILITIES | |||||||||||
| Commitments and contingencies | |||||||||||
| Stockholders' Equity | |||||||||||
| Preferred stock | |||||||||||
| Series A Preferred Stock | |||||||||||
| Undesignated | |||||||||||
| Common stock: $0.001 par value, 400,000,000 shares authorized, 53,733,083 shares issued and outstanding as of March 31, 2026 and 22,933,083 shares issued and outstanding as of December 31, 2025 | |||||||||||
| Subscription receivable | |||||||||||
| Additional paid-in capital | |||||||||||
| Accrued compensation expense | |||||||||||
| Accumulated deficit | |||||||||||
| Accumulated other comprehensive income | |||||||||||
| Total stockholders' equity | |||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
